Author

D. Thevenin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Approach:wet-lab / biochemical assay· 2 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

E. Bloch· 2 shared E. L. Sikorski· 2 shared J. Wehr· 2 shared M. M. Pires· 2 shared N. J. Ferraro· 2 shared A. E. Snook· 1 shared B. W. Berger· 1 shared D. Pontoriero· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

E. Bloch

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Targeted Acidosis Mediated Delivery of Antigenic MHC-Binding Peptides

J. J. Kelly, E. Ankrom, D. Thevenin, M. Pires

This study uses pH-sensitive peptides to deliver MHC-binding antigens to cancer cells, enhancing T cell activation for immunotherapy.

bioRxiv · Oct 18, 2023Cancer Biology

Selective Display of a Chemoattractant Agonist on Cancer Cells Activates the Formyl Peptide Receptor 1 on Immune Cells

E. L. Sikorski, J. Wehr, N. J. Ferraro, M. M. Pires, D. Thevenin

The paper designs a bifunctional agent using pHLIP to selectively display a chemoattractant agonist on cancer cells, activating formyl peptide receptors on immune cells to initiate an immune response.

bioRxiv · Sep 27, 2021Immunology

Disrupting the Transmembrane Domain Oligomerization of Protein Tyrosine Phosphatase Receptor J Promotes its Activity in Cancer Cells

E. Bloch, E. Sikorski, D. Pontoriero, B. W. Berger, M. J. Lazzara, D. Thevenin

This study shows that disrupting the transmembrane domain oligomerization of PTPRJ enhances its activity, reduces EGFR phosphorylation, and promotes substrate access in cancer cells.

bioRxiv · Oct 7, 2019Biochemistry

pH-Dependent Grafting of Cancer Cells with Antigenic Epitopes Promotes Selective Antibody-Mediated Cytotoxicity

J. Wehr, E. L. Sikorski, E. Bloch, M. S. Feigman, N. J. Ferraro, T. Baybutt, A. E. Snook, M. M. Pires, D. Thevenin

This study develops pH-dependent conjugates that graft antigenic epitopes onto cancer cells to enhance antibody-mediated cytotoxicity.

bioRxiv · Sep 30, 2019Immunology